Medicine and Dentistry
Acute Myeloid Leukemia
100%
Anthracycline
33%
Combination Therapy
66%
Continuous Infusion
33%
Cytarabine
100%
Development
33%
Disease
33%
Inpatient
66%
Liposomal Daunorubicin
100%
Obstetric Delivery
33%
Overall Survival
33%
Pathogenesis
33%
Secondary Acute Myeloid Leukemia
100%
Survival
33%
Therapeutic Procedure
33%
Nursing and Health Professions
Acute Myeloid Leukemia
100%
Anthracycline
33%
Combination Therapy
66%
Continuous Infusion
33%
Cytarabine
100%
Daunorubicin
100%
Diseases
33%
Encapsulation
33%
Food and Drug Administration
66%
Obstetric Delivery
33%
Overall Survival
33%
Pathogenesis
33%
Preclinical Study
33%
Prognostication
66%
Survival
33%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Anthracycline
33%
Cytarabine
100%
Daunorubicin
100%
Diseases
33%
Overall Survival
33%
Pathogenesis
33%
Secondary Acute Myeloid Leukemia
100%
Survival
33%